Sort
10,766 grants matching “checkpoint inhibitor”
Identifying novel resistance mechanisms in non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin (BCG)
$187,642John Sfakianos · Icahn School Of Medicine At Mount Sinai · R21 · FY2024 · CA
Improving decision-making in patients with resectable melanoma and pre-existing autoimmune disease considering immune checkpoint inhibition
$187,514Maria De Los Angeles Lopez-Olivo · University Of Tx Md Anderson Can Ctr · K08 · FY2022 · CA
Signaling Mechanisms in Genome Maintenance (Equipment Supplement 2023)
$187,421Marcus Smolka · Cornell University · R35 · FY2023 · GM
Development Therapeutics Branch Clinical Trials
$187,121Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Developing GRB2-PROTACs for Treatment of Lung Cancer
$187,087Haitao Mark Ji · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2024 · CA
Autoimmunity in Cardiopulmonary Toxicities from Radiotherapy and Immunotherapy
$186,978Bo Lu · Thomas Jefferson University · R01 · FY2021 · CA
Prediction and Treatment for Cancer Immunotherapy Induced Myocarditis
$186,875Hua Pan · University Of South Florida · R21 · FY2021 · HL
Dissecting the interactions between TCR signaling strength and inhibitory pathways
$186,840Lin Shen · University Of Chicago · K08 · FY2025 · AI
Dissecting the interactions between TCR signaling strength and inhibitory pathways
$186,840Lin Shen · University Of Chicago · K08 · FY2024 · AI
Endocrine tissue molecular pathways dysregulated by immune checkpoint inhibitors causing ICI-triggered adverse events
$186,532Yaron Tomer · Albert Einstein College Of Medicine · R21 · FY2024 · CA
Deregulation of the Ubiquitin/26S Proteasome Pathway in AT cells: Role of ISG15
$186,375Shyamal D Desai · Lsu Health Sciences Center · R21 · FY2009 · NS
Remotely controlled listerial bactodrones for cancer immunotherapy
$186,018Mark Gomelsky · University Of Wyoming · R21 · FY2021 · CA
CORRELATIVE SCIENCE CORE
$185,997Jon C Aster · Brigham And Women'S Hospital · P50 · FY2018 · CA
Enhancing Melanoma TIL Efficacy with Multifactor mRNA-Mediated T Cell Reprogramming
$185,977Samuel G Katz · Yale University · R21 · FY2024 · CA
Regulation of BRCA1 Function by Protein Phosphatase 1
$185,920Lih-Ching Hsu · Magee-Women'S Res Inst And Foundation · R01 · FY2007 · CA
Analysis of lung cancer stem cell radioresistance
$185,845Vera Levina · University Of Pittsburgh At Pittsburgh · R21 · FY2013 · CA
Redefining hemophagocytic lymphohistiocytosis in hematologic malignancies
$185,831Michael Jordan · Cincinnati Childrens Hosp Med Ctr · R21 · FY2021 · CA
Discovery of PD-1/PDL-1 inhibitors from marine microbial natural products
$185,808William Fenical · University Of California, San Diego · R01 · FY2023 · CA
Discovery of PD-1/PDL-1 inhibitors from marine microbial natural products
$185,807William Fenical · University Of California, San Diego · R01 · FY2022 · CA
Project 2: Chemotherapy-induced Immunomodulation in Colon Cancer
$185,625Pran K Datta · University Of Alabama At Birmingham · U54 · FY2021 · CA
Prostate cancer-associated SPOP mutations modulate innate immune response and immune checkpoint therapy
$185,552Timothy C Thompson · University Of Tx Md Anderson Can Ctr · R21 · FY2022 · CA
PVSRIPO in melanoma
$185,397Georgia Beasley · Duke University · K08 · FY2024 · CA
Molecular Targeting of the Survivin Pathway in Cancer
$185,238Univ Of Massachusetts Med Sch Worcester · R01 · FY2002 · CA
Metabolic basis of ARID1A-mutated ovarian cancer
$184,954Rugang Zhang · Wistar Institute · R01 · FY2022 · CA
In vivo CRISPR-screening of novel cancer cell-intrinsic targets that sensitize to local ionizing radiation, and possible combination with systemic checkpoint blockade.
$184,822Ralph R Weichselbaum · University Of Chicago · R21 · FY2023 · CA